Ruth Bader Ginsburg’s cancer is back
![Ruth Bader Ginsburg has been treated for cancer for the fourth time](https://images.forwardcdn.com/image/970x/center/images/cropped/ruth-bader-fiddler-roof-1566587434.jpg)
Ruth Bader Ginsburg was recently treated for cancer for a fourth time Image by Getty Images
Supreme Court Justice Ruth Bader Ginsburg announced Friday that her cancer has returned.
“I have often said I would remain a member of the court as long as I can do the job full steam,” said Ginsburg, 87, in a statement. “I remain fully able to do that.”
Ginsburg began chemotherapy on May 19 after doctors discovered lesions on her liver, likely a result of pancreatic cancer, the Washington Post reported.
She had surgery for early-stage pancreatic cancer in 2009 and was treated for colon cancer in 1999. More recently, she’s had surgery for lung cancer and treatment for pancreatic cancer.
Ginsburg’s statement said she would continue chemotherapy biweekly and said she is “encouraged” by the success of the treatment so far.
Correction, July 20, 9:09 a.m.: A previous version of this story stated that Justice Ginsburg has liver cancer. In fact, she has pancreatic cancer which has metastasized to her liver.
A message from our CEO & publisher Rachel Fishman Feddersen
![](https://forward.com/wp-content/uploads/2024/04/image.png?_t=1722445328)
I hope you appreciated this article. Before you go, I’d like to ask you to please support the Forward’s award-winning, nonprofit journalism during this critical time.
Now more than ever, American Jews need independent news they can trust, with reporting driven by truth, not ideology. We serve you, not any ideological agenda.
At a time when other newsrooms are closing or cutting back, the Forward has removed its paywall and invested additional resources to report on the ground from Israel and around the U.S. on the impact of the war, rising antisemitism and the protests on college campuses.
Readers like you make it all possible. Support our work by becoming a Forward Member and connect with our journalism and your community.
— Rachel Fishman Feddersen, Publisher and CEO